Gene · 1317
Papers1,953
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,953
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical significance and immune microenvironment association of cuproptosis-related genes in pan-cancer. | Exp Physiol | 2026 | 40560740 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
| [Mechanism of ginsenoside Rb_1 in ameliorating hypoxia/reoxygenation injury in H9c2 cardiomyocytes through CTR1 ubiquitination-mediated regulation of cuproptosis]. | Zhongguo Zhong Yao Za Zhi | 2025 | 41507748 | PubTator, text mining | PubMed |
| Tumor CTR1 and serum copper dynamics reveal a coordinated copper axis linked to high-grade triple-negative breast cancer biology. | medRxiv | 2025 | 41480020 | PubTator, text mining | PubMed |
| Human CTR1 Through the Ages: Milestones and Emerging Roles in Disease and Therapy. | Biomolecules | 2025 | 41463392 | PubTator, text mining | PubMed |
| Elevated intracellular copper induces CTR1 monomerization and prevents copper uptake. | Nat Commun | 2025 | 41387689 | PubTator, text mining | PubMed |
| Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort. | Genes (Basel) | 2025 | 41300713 | PubTator, text mining | PubMed |
| Aged microplastics disrupted copper homeostasis to induce vascular toxicity: in vivo and human vascular organoids-based in vitro study. | Environ Int | 2025 | 41270660 | PubTator, text mining | PubMed |
| Relationship between the expression of copper death promoting factor SLC31A1 in papillary thyroid carcinoma and clinicopathological indicators and prognosis. | Open Med (Wars) | 2025 | 41216190 | PubTator, text mining | PubMed |
| Molecular dynamics study of the impact of glycosylation on conformational properties of trimeric N-terminal domain of human copper transporter 1. | Carbohydr Res | 2025 | 41130030 | PubTator, text mining | PubMed |
| Cuproptosis Facilitates Chronic Skin Inflammation by Regulating the α-Ketoglutarate/H3K4me3/Ferritin Heavy Chain 1 Signaling Pathway-Mediated Ferroptosis. | MedComm (2020) | 2025 | 41064128 | PubTator, text mining | PubMed |
| Clinical and molecular characterization of SLC31A1-related developmental and epileptic encephalopathy: insights from 13 new cases. | Brain Commun | 2025 | 41040850 | PubTator, text mining | PubMed |
| Critical Review of Hearing Rehabilitation in Pediatric Oncology: Specific Considerations and Barriers. | Curr Oncol | 2025 | 41002579 | PubTator, text mining | PubMed |
| Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance. | Mol Cancer | 2025 | 40999456 | PubTator, text mining | PubMed |
| RAD23B acquires a copper metalloadaptor function in amphibian-to-reptile evolution to increase metabolism and regulate genomic integrity. | Mol Cell | 2025 | 40972527 | PubTator, text mining | PubMed |
| Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis. | Cancer Med | 2025 | 40888184 | PubTator, text mining | PubMed |
| Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity. | Nat Commun | 2025 | 40885711 | PubTator, text mining | PubMed |
| Cuproptosis-related signature and immune infiltration in age-related macular degeneration. | Int J Ophthalmol | 2025 | 40881432 | PubTator, text mining | PubMed |
| Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis. | Mol Cancer | 2025 | 40859310 | PubTator, text mining | PubMed |
| Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms. | Clin Epigenetics | 2025 | 40851017 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1317/papers?page=5